EMA Recommends Approval of Groundbreaking CRISPR/Cas9 Therapy for Beta Thalassemia and Sickle Cell Disease
Understanding Tuberculosis Risk Among Household Contacts: Insights from Brazil’s Nationwide Cohort Study